V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220006182 | 220011354 | 1.72 | 68.2 | Curative (C) | 2017-10-06 | 2017-10-08 | FLAG + Idarubicin | N | N | 220029773 | FLAG + IDARUBICIN |
| 220006183 | 220002402 | 1.68 | 69.6 | Curative (C) | 2017-07-13 | 2017-07-14 | FLAG + Idarubicin | null | null | 220029778 | FLAG + IDARUBICIN |
| 220006184 | 220002402 | null | 78.9 | Disease modification (D) | null | 2016-02-17 | Nilotinib | N | N | 220029778 | NILOTINIB |
| 220006185 | 220002402 | 1.66 | 0 | null | 2015-12-10 | 2015-12-12 | Nilotinib | N | N | 220029778 | NILOTINIB |
| 220006186 | 220002402 | 1.57 | 107 | Curative (C) | 2014-01-01 | 2014-01-01 | AML 19 TRIAL | Y | N | 220029778 | AML19 TRIAL |
| 220006187 | 220002403 | 1.52 | 71.5 | Curative (C) | 2014-12-19 | 2014-12-19 | AML 19 TRIAL | 2 | N | 220029785 | AML19 TRIAL |
| 220006188 | 220002404 | 0 | 86 | Palliative (P) | null | 2014-08-12 | Nilotinib | N | N | 220029786 | NILOTINIB |
| 220006189 | 220002404 | null | 73 | Adjuvant (A) | 2015-03-03 | 2015-03-05 | FLAG + Idarubicin | N | null | 220029786 | FLAG + IDARUBICIN |
| 220006190 | 220002404 | 1.75 | 98 | Curative (C) | 2015-06-30 | 2015-07-01 | AML 19 TRIAL | 1 | N | 220029786 | AML19 TRIAL |
| 220006191 | 220002404 | 1.03 | 12.1 | Curative (C) | 2017-11-26 | 2017-11-29 | null | 02 | N | 220029786 | NOT MATCHED |
| 220006192 | 220002404 | 0 | 0 | Palliative (P) | null | 2013-01-27 | Nilotinib | 02 | N | 220029786 | NILOTINIB |
| 220006193 | 220002404 | 1.77 | 82 | Curative (C) | 2016-11-12 | 2016-11-22 | AML 19 TRIAL | Y | N | 220029786 | AML19 TRIAL |
| 220006194 | 220002404 | null | null | Palliative (P) | 2016-07-22 | 2016-07-25 | Nilotinib | N | N | 220029786 | NILOTINIB |
| 220006195 | 220002404 | null | 61.8 | Curative (C) | 2014-09-03 | 2014-09-03 | AML 19 TRIAL | 01 | N | 220029786 | AML19 TRIAL |
| 220006196 | 220002404 | 1.68 | 80 | Curative (C) | 2013-09-04 | 2013-09-04 | AML 19 TRIAL | N | N | 220029786 | AML19 TRIAL |
| 220006197 | 220022242 | 0 | null | Curative (C) | 2015-05-28 | 2015-05-28 | Nilotinib | 02 | N | 220029799 | NILOTINIB |
| 220006198 | 220022242 | 1.62 | 68.8 | Curative (C) | 2013-01-31 | 2013-01-31 | AML 19 TRIAL | Y | N | 220029799 | AML19 TRIAL |
| 220006199 | 220022320 | 1.76 | 101.8 | Disease modification (D) | 2014-06-27 | 2014-07-07 | FLAG + Idarubicin | null | null | 220029805 | FLAG + IDARUBICIN |
| 220006200 | 220022338 | 1.56 | 65.8 | Curative (C) | 2013-01-29 | 2013-02-01 | AML 19 TRIAL | 1 | N | 220029806 | AML19 TRIAL |
| 220006201 | 220002405 | 1.68 | 79.2 | Curative (C) | 2015-02-17 | 2015-02-17 | AML 19 TRIAL | Y | null | 220029807 | AML19 TRIAL |
| 220006202 | 220002405 | 0 | 0 | Curative (C) | 2015-12-23 | 2015-12-23 | Nilotinib | N | N | 220029807 | NILOTINIB |
| 220006203 | 220002406 | null | null | Curative (C) | 2017-09-30 | 2017-10-14 | Nilotinib | N | N | 220029810 | NILOTINIB |
| 220006204 | 220011358 | 1.72 | 73 | Curative (C) | 2017-10-28 | 2017-10-28 | FLAG + Idarubicin | null | null | 220029812 | FLAG + IDARUBICIN |
| 220006205 | 220011358 | 1.69 | 86.5 | Curative (C) | 2013-06-15 | 2013-06-15 | FLAG + Idarubicin | N | N | 220029812 | FLAG + IDARUBICIN |
| 220006206 | 220011358 | 0 | null | Disease modification (D) | 2015-06-16 | 2015-06-17 | Nilotinib | 02 | N | 220029812 | NILOTINIB |
| 220006207 | 220011358 | 1.73 | 80 | null | null | 2013-01-18 | FLAG + Idarubicin | 02 | null | 220029812 | FLAG + IDARUBICIN |
| 220006208 | 220011358 | 1.66 | 97.5 | Curative (C) | 2013-10-23 | 2013-10-23 | Nilotinib | N | N | 220029812 | NILOTINIB |
| 220006209 | 220011358 | 0 | null | Unknown (U) | 2014-01-27 | 2014-01-27 | Nilotinib | 02 | N | 220029812 | NILOTINIB |
| 220006210 | 220002407 | null | 0 | Palliative (P) | 2013-09-17 | 2015-02-24 | Nilotinib | 2 | N | 220029825 | NILOTINIB |
| 220006211 | 220002408 | null | 75.8 | Curative (C) | 2014-11-28 | 2014-11-28 | AML 19 TRIAL | Y | N | 220029826 | AML19 TRIAL |
| 220006212 | 220002408 | 1.6 | null | Curative (C) | 2015-06-13 | 2015-06-17 | Nilotinib | 02 | N | 220029826 | NILOTINIB |
| 220006213 | 220002408 | 1.82 | 78 | Curative (C) | 2014-07-04 | 2014-07-04 | AML 19 TRIAL | 01 | N | 220029826 | AML19 TRIAL |
| 220006214 | 220002409 | 1.82 | 53.9 | Disease modification (D) | 2015-10-08 | 2015-10-08 | AML 19 TRIAL | Y | N | 220029833 | AML19 TRIAL |
| 220006215 | 220002409 | 1.57 | 106 | Curative (C) | 2015-11-09 | 2015-11-17 | AML 19 TRIAL | 01 | N | 220029833 | AML19 TRIAL |
| 220006216 | 220002409 | null | 84.9 | Curative (C) | 2015-12-16 | 2015-12-29 | Nilotinib | N | N | 220029833 | NILOTINIB |
| 220006217 | 220002409 | null | 0 | null | 2013-12-23 | 2013-12-26 | Nilotinib | N | N | 220029833 | NILOTINIB |
| 220006218 | 220002409 | null | 102.6 | Curative (C) | 2014-09-17 | 2014-09-17 | AML 19 TRIAL | Y | N | 220029833 | AML19 TRIAL |
| 220006225 | 220002412 | 0 | 0 | Curative (C) | 2016-08-15 | 2016-08-15 | Nilotinib | null | N | 220029856 | NILOTINIB |
| 220006226 | 220002412 | 1.6 | 77.1 | Curative (C) | 2017-02-25 | 2017-02-25 | FLAG + Idarubicin | N | N | 220029856 | FLAG + IDARUBICIN |
| 220006227 | 220002412 | 1.75 | 72 | Curative (C) | 2013-02-19 | 2013-02-20 | AML 19 TRIAL | N | N | 220029856 | AML19 TRIAL |
| 220006228 | 220002413 | 0 | 0 | Adjuvant (A) | 2015-08-12 | 2015-08-12 | Nilotinib | 2 | N | 220029869 | NILOTINIB |
| 220006229 | 220002413 | null | 72 | Disease modification (D) | 2015-12-20 | 2016-01-04 | Nilotinib | null | N | 220029869 | NILOTINIB |
| 220006230 | 220002413 | 1.66 | null | Curative (C) | 2017-07-03 | 2017-07-06 | Nilotinib | 99 | N | 220029869 | NILOTINIB |
| 220006231 | 220002413 | null | null | Palliative (P) | 2013-01-28 | 2013-02-18 | Nilotinib | 02 | N | 220029869 | NILOTINIB |
| 220006232 | 220002413 | 1.55 | 81.9 | Curative (C) | 2016-09-02 | 2016-09-04 | AML 19 TRIAL | 1 | N | 220029869 | AML19 TRIAL |
| 220006233 | 220002413 | null | 60 | Palliative (P) | 2015-03-27 | 2015-03-27 | CYTARABINE + Hydroxycarbamide | N | N | 220029869 | NOT MATCHED |
| 220006234 | 220002413 | 0 | null | Curative (C) | null | 2017-08-07 | Nilotinib | 02 | N | 220029869 | NILOTINIB |
| 220006235 | 220002414 | 0 | 91.7 | Not known (9) | 2017-01-11 | 2017-01-11 | Nilotinib | 02 | N | 220029889 | NILOTINIB |
| 220006236 | 220002414 | 1.55 | 78 | Curative (C) | null | 2015-05-12 | AML 19 TRIAL | N | N | 220029889 | AML19 TRIAL |
| 220006237 | 220002414 | null | 0 | Curative (C) | null | 2014-02-18 | Nilotinib | N | null | 220029889 | NILOTINIB |